Contineum Therapeutics, Inc. CTNM · News

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of s...

Price10.3

Market Cap404.44 M

Float39.09 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Search in Documents